Search This Blog

Tuesday, May 7, 2019

Aerie Pharma backs FY19 revenue view $110-120M, consensus $113.02M

Backs forecast for FY19 cash burn of $130M-$140M

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.